ANTIHYPERTENSIVE EFFICACY OF OLMESARTAN MEDOXOMIL, A NEW ANGIOTENSIN II RECEPTOR ANTAGONIST, AS ASSESSED BY AMBULATORY BLOOD PRESSURE MEASUREMENTS

Por J. M. Neutel, W. J. Elliott, J. L. Izzo, C. L. Chen, H. N. Masonson
Publicado em 2011-04-01